A multi-omic platform with multi-market returns
⭐ A Platform Shift

A New Standard for Diagnostics

A multi-billion-dollar diagnostics market
constrained by legacy technologies
and ready for a platform shift.

Guanine is building the universal sensing layer for diagnostics—replacing fragmented, single-purpose technologies with one scalable platform.

Investment Highlights

Go-To-Market Strategy

A phased go-to-market strategy anchored in near-term clinical entry and platform expansion.


⭐ Why Now

The Diagnostic Landscape Has Shifted—Permanently

Guanine is purpose-built for this new diagnostic reality.

Clinical Drivers

  • Sepsis and AMR require rapid, actionable data
  • Drug susceptibility must move beyond culture
  • Clinicians need integrated host–pathogen-drug insight

Economic Drivers

  • Hospitals face severe cost and staffing pressures
  • Diagnostics must move closer to the patient and reduce system burden

OEM & Technology Drivers

  • Optical platforms are hitting hard multiplexing limits
  • AI requires high-plex, quantitative multi-omic data
  • Precision health depends on high-plex, quantitative biomarker data at low cost